关于东亚肥胖和代谢功能障碍相关的脂肪肝炎的当前趋势和前景
Soo Lim1, Zhou Hui2, Wataru Ogawa3
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Journal of obesity & metabolic syndrome
|March 2, 2026
概括
肥胖和代谢功能障碍相关的脂肪肝炎 (MASH) 是东亚越来越多的公共卫生问题. 对于这个不断增长的人口,迫切需要改进的诊断工具和治疗方法.
科学领域:
- 公共卫生 公共卫生
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
背景情况:
- 肥胖是一种全球性流行病,在东亚国家迅速增加.
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是肥胖的日益严重的并发症,特别是在东亚.
- 东亚人群面临着独特的风险,包括较低的BMI和高风险脂肪类型的瘦肉MASH.
研究的目的:
- 突出东亚肥胖和MASH日益严重的公共卫生挑战.
- 确定东亚人群中MASH目前的诊断工具和治疗方法的局限性.
- 强调需要提高认识,改进非侵入性测试 (NIT) 和新的治疗策略.
主要方法:
- 对东亚肥胖和MASH患病率和风险因素的当前文献的综述.
- 在东亚人群中分析全球非侵入性测试 (NIT) 的有效性.
- 评估东亚患者在肥胖和MASH的临床试验中的代表性不足.
主要成果:
- 目前对MASH的非侵入性测试 (NIT) 缺乏在东亚人群中有效性的足够证据.
- 东亚患者在全球临床试验中代表性不足,限制了治疗开发.
- 需要提高意识,可访问的诊断工具和有效的治疗方法.
结论:
- 肥胖和MASH在东亚带来了重大和日益严重的公共卫生问题.
- 发展特定区域的NIT和增加参与临床试验至关重要.
- 预防和管理需要改进教育策略和医疗保健基础设施.
相关概念视频
Overview of Lipid Metabolism
6.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
257
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
257
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
326
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
326
Overview of Fatty Acid Metabolism
37.5K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.5K
Drug Dosing: Obese Patients
317
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
317


